Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Dental Erosions in GORD
NCT00564330Phase 2Completed
- Sponsor
- Brain-Gut Research Group
- Start
- Nov 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by Brain-Gut Research Group. Started Nov 2007; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00564330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564330.